1. Home
  2. ELDN vs FDBC Comparison

ELDN vs FDBC Comparison

Compare ELDN & FDBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ELDN
  • FDBC
  • Stock Information
  • Founded
  • ELDN 2004
  • FDBC 1902
  • Country
  • ELDN United States
  • FDBC United States
  • Employees
  • ELDN N/A
  • FDBC N/A
  • Industry
  • ELDN Biotechnology: Pharmaceutical Preparations
  • FDBC Major Banks
  • Sector
  • ELDN Health Care
  • FDBC Finance
  • Exchange
  • ELDN Nasdaq
  • FDBC Nasdaq
  • Market Cap
  • ELDN 288.5M
  • FDBC 253.4M
  • IPO Year
  • ELDN N/A
  • FDBC N/A
  • Fundamental
  • Price
  • ELDN $4.09
  • FDBC $44.86
  • Analyst Decision
  • ELDN Strong Buy
  • FDBC
  • Analyst Count
  • ELDN 1
  • FDBC 0
  • Target Price
  • ELDN $16.00
  • FDBC N/A
  • AVG Volume (30 Days)
  • ELDN 520.7K
  • FDBC 9.0K
  • Earning Date
  • ELDN 11-12-2024
  • FDBC 01-27-2025
  • Dividend Yield
  • ELDN N/A
  • FDBC 3.68%
  • EPS Growth
  • ELDN N/A
  • FDBC N/A
  • EPS
  • ELDN N/A
  • FDBC 2.68
  • Revenue
  • ELDN N/A
  • FDBC $71,243,000.00
  • Revenue This Year
  • ELDN N/A
  • FDBC N/A
  • Revenue Next Year
  • ELDN N/A
  • FDBC N/A
  • P/E Ratio
  • ELDN N/A
  • FDBC $16.25
  • Revenue Growth
  • ELDN N/A
  • FDBC N/A
  • 52 Week Low
  • ELDN $1.52
  • FDBC $41.00
  • 52 Week High
  • ELDN $5.54
  • FDBC $61.21
  • Technical
  • Relative Strength Index (RSI)
  • ELDN 47.03
  • FDBC 39.76
  • Support Level
  • ELDN $3.68
  • FDBC $42.62
  • Resistance Level
  • ELDN $4.19
  • FDBC $45.27
  • Average True Range (ATR)
  • ELDN 0.32
  • FDBC 1.43
  • MACD
  • ELDN -0.04
  • FDBC -0.04
  • Stochastic Oscillator
  • ELDN 31.54
  • FDBC 43.86

About ELDN Eledon Pharmaceuticals Inc.

Eledon Pharmaceuticals Inc is a clinical-stage biotechnology company. The firm is focused on transplantation and autoimmune diseases. It targets CD40L pathway to develop potential treatments for patients living with an autoimmune disease, patients requiring an organ or cell-based transplant, and for patients living with ALS. The company's compound in development is tegoprubart, an IgG1, anti-CD40L antibody with high affinity for the CD40 Ligand, a well-validated biological target that has broad therapeutic potential.

About FDBC Fidelity D & D Bancorp Inc.

Fidelity D & D Bancorp Inc is a bank holding company. Through its wholly-owned state-chartered commercial bank subsidiary, The Fidelity Deposit and Discount Bank (the Bank), it offers a full range of traditional banking services. The Bank has a personal and corporate trust department and also provides alternative financial and insurance products with asset management services. Its primary market areas are Lackawanna, Luzerne and Northampton Counties, Pennsylvania. The company's primary deposit products are demand deposits and interest-bearing time, money market and savings accounts. It offers a full array of loan products to meet the needs of retail and commercial customers.

Share on Social Networks: